|
Volumn 166, Issue , 2001, Pages 111-123
|
Quantification of immunotoxin number for complete therapeutic response.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
B3(FV) PE38KDEL RECOMBINANT IMMUNOTOXIN;
B3(FV)-PE38KDEL RECOMBINANT IMMUNOTOXIN;
BACTERIAL TOXIN;
EXOTOXIN;
HYBRID PROTEIN;
IMMUNOTOXIN;
INTERLEUKIN 2 RECEPTOR;
MONOCLONAL ANTIBODY;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;
TOXA PROTEIN, PSEUDOMONAS AERUGINOSA;
VIRULENCE FACTOR;
ANIMAL;
CANCER STEM CELL;
CANCER TRANSPLANTATION;
DOSE RESPONSE;
DRUG EFFECT;
DRUG SCREENING;
EXPERIMENTAL LEUKEMIA;
GENETIC TRANSFECTION;
HUMAN;
IMMUNOLOGY;
LEUKEMIA;
LYMPHOMA;
MOUSE;
MOUSE MUTANT;
NEOPLASM;
NUDE MOUSE;
PHASE 1 CLINICAL TRIAL;
PROTEIN BINDING;
REMISSION;
REVIEW;
SUBCUTANEOUS DRUG ADMINISTRATION;
TISSUE DISTRIBUTION;
ADP RIBOSE TRANSFERASES;
ANIMALS;
ANTIBODIES, MONOCLONAL;
BACTERIAL TOXINS;
CLINICAL TRIALS, PHASE I;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG SCREENING ASSAYS, ANTITUMOR;
EXOTOXINS;
HUMANS;
IMMUNOTOXINS;
INJECTIONS, SUBCUTANEOUS;
LEUKEMIA;
LEUKEMIA, EXPERIMENTAL;
LYMPHOMA;
MICE;
MICE, NUDE;
MICE, SCID;
NEOPLASM TRANSPLANTATION;
NEOPLASMS;
PROTEIN BINDING;
RECEPTORS, INTERLEUKIN-2;
RECOMBINANT FUSION PROTEINS;
REMISSION INDUCTION;
TISSUE DISTRIBUTION;
TRANSFECTION;
TUMOR STEM CELLS;
VIRULENCE FACTORS;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 0035220366
PISSN: 10643745
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (2)
|
References (35)
|